NL-OMON22000尚未招募不适用
Co-infusion of haematopoietic stem cells from a haplo-identical donor and single unit unrelated cord blood in patients with a high risk of relapse:A Phase l/ll study to assess safety and to investigate the biological mechanism of the anti-tumor response.
MC Utrecht0 个研究点目标入组 37 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 37
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with either:
- •A. No standard HSCT protocol available and any of the following malignancies: NHL or HD (refractory, ≥2CR); relapse AML/refractory AML, MDS, SAA, ALL ≥CR2;
排除标准
- •1. Creatinine clearance < 40 ml/min;
- •2. Cardiac dysfunction (SF < 30%) (Ejection fraction < 45%), unstable angina, or unstable cardiac arrhythmias;
研究者
相似试验
已完成
2 期
Co-infusion of haematopoietic stem cells from a haplo-identical donor and single unit unrelated cord blood in patients with a high risk of relapse: A Phase l/ll study to assess safety and to investigate the biological mechanism of the anti-tumor responseleukemia10018849hematological malignancyNL-OMON35879niversitair Medisch Centrum Utrecht5
进行中（未招募）
不适用
Haploidentical stem cell transplantation for paediatric patients with thalassemia majorThalassemia majorHaematological DisordersBeta thalassaemiaISRCTN54428419Shenzhen Children's Hospital200
进行中（未招募）
1 期
Stem cells transplant from matched donor in patients with chronic myeloid leukemia who do not improve with TKI therapyChronic Myeloid LeukemiaMedDRA version: 18.0Level: LLTClassification code 10054352Term: Chronic phase chronic myeloid leukemiaSystem Organ Class: 100000004864EUCTR2014-003126-40-ITIVERSITà DEGLI STUDI MILANO BICOCCA20
招募中
2 期
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) SyndromeImmunodeficiencyHematopoietic Stem Cell TransplantationNCT05027945National Cancer Institute (NCI)54
招募中
2 期
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of ImmunityLymphoproliferative DisordersAutoimmune LymphoproliferativeImmune System DiseasesPrimary T-cell Immunodeficiency DisordersCommon Variable ImmunodeficiencyNCT04339777National Cancer Institute (NCI)66